Similar to other studies our clusters differentiate between canonical breast cancer molecular subtypes: Cluster-1 and Cluster-2 containt the majority of patients with Luminal A/B type tumors while Cluster-3 contains the majority of patients with Basal-like tumors and as expected is enriched for samples negative for ER, PR, or HER2. This evidence concerns the gene ERBB2 and breast cancer.